Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress 2021-06-07 12:00
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General 2021-06-07 11:35
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021 2021-06-07 10:11
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021 2021-06-07 10:10
BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June 2021-06-07 10:00
Hyperice Named Official Recovery Technology Partner by League of Legends Pro League 2021-06-07 10:00
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting 2021-06-07 10:00
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021 2021-06-07 09:53
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication 2021-06-07 08:30
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries 2021-06-07 08:00
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting 2021-06-07 08:00
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™, phase III results at ASCO 2021 2021-06-05 20:00
Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product 2021-06-05 01:32
Advaccine Announces First Participants Dosed in Phase 2 Study of ADV110 Evaluating Respiratory Syncytial Virus (RSV) Vaccine Candidate in Australia 2021-06-04 20:05
Second Global Health Forum of Boao Forum for Asia Deepens Understanding of Universal Health and Global Cooperation 2021-06-04 20:03
WhaleTeq Launches First AED Management Platform with DFS200 to Provide Most Effective and Efficient Maintenance Solution 2021-06-04 19:38
VeChain, Together With DNV, Enables Renji Hospital To Launch The World's First Blockchain-based IVF Service App - MyBaby 2021-06-04 18:39
1 325 326 327 328 329 739